• Endometrium Hyperplastic Processes. Correction resources of naturopathic preparations

Endometrium Hyperplastic Processes. Correction resources of naturopathic preparations

HEALTH OF WOMAN. 2017.4(120):47–52; doi 10.15574/HW.2017.120.47

Tsubanova N. A., Barskaya A. V., Gubchenko T. D. 
National Pharmaceutical University, Kharkov

The article presents modern aspects of etiopathogenetic factors of endometrium hyperplastic processes. Modern data on the classification, diagnosis and therapy of endometrial hyperplasia was analyzed. The possibility of using modern naturopathic drugs «Normomens» on the basis of extracts of Vitex agnus castus, Zingiber officinale, Trigonella foenum graecum, Pyrus malus and «Normocycle» containing extracts of Symplocos racemosa, Asparagus racemosus, Glycyrrhiza glabra, Curcuma longa was theoretically substantiated in the therapy of endometrium hyperplastic processes.

Key words: endometrium hyperplastic processes, Normomens, Normocycle.

REFERENCES

1. Ginekologiya: natsionalnoe rukovodstvo. Pod. red. VI Kulakova, IB Manuhina, GM Savelevoy. M, GEOTAR-Media. 2007:761–783.

2. Znachenie prutnyaka obyiknovennogo v ginekologicheskoy endokrinologii. Zdorov’ya UkraYini. 2012. 9:3–4.

3. Kiselev VI, Sidorova IS, Unanyan AL, Muyzhnek EL. 2010. Giperplasticheskie protsessyi organov zhenskoy reproduktivnoy sistemyi. M, MEDPRAKTIKA-M:467.

4. Kuznetsova IV. 2010. Vozmozhnosti terapii giperplasticheskih protsessov endometriya. Trudnyiy patsient 1:12–16.

5. Potapov VA. 2014. Normomens – optimalnaya naturopaticheskaya retseptura lecheniya predmenstrualnogo sindroma. Zdorove zhenschinyi 6:137–142.

6. Acharya N, Acharya S, Shah U et al. 2016. A comprehensive analysis on Symplocos racemosa Roxb.: Traditional uses, botany, phytochemistry and pharmacological activities. J Ethnopharmacol. 181:236–251. https://doi.org/10.1016/j.jep.2016.01.043; PMid:26851499

7. Lacey JV, Sherman ME, Rush BB et al. 2010. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol. 28:788–792. https://doi.org/10.1200/JCO.2009.24.1315; PMid:20065186 PMCid:PMC2834395

8. Abu Hashim H, Ghayaty E, El Rakhawy M. 2015. Levonorgestrelreleasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 213:469–478. https://doi.org/10.1016/j.ajog.2015.03.037; PMid:25797236

9. Tiwari N, Gupta VK, Pandey P et al. 2017. Adjuvant effect of Asparagus racemosus Willd. derived saponins in antibody production, allergic response and pro-inflammatory cytokine modulation. Biomed Pharmacother. 86:555–561. https://doi.org/10.1016/j.biopha.2016.11.087; PMid:28024292

10. Plangsombat N, Rungsardthong K, Kongkaneramit L et al. 2016. Anti-inflammatory activity of liposomes of Asparagus racemosus root extracts prepared by various methods. Exp Ther Med. 12(4):2790–2796. https://doi.org/10.3892/etm.2016.3661

11. Ramesh BK, Raghavendra HL, Kantikar SM et al. 2010. Antidiabetic and histopathological analysis of fenugreek extract on alloxan induced diabetic rats. International Journal of Drug Development and Research 2(2):356–364.

12. Ozdegirmenci O, Kayikcioglu F, Bozkurt U et al. 2011. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia. Gynecol Obstet Invest. 72:10–14. https://doi.org/10.1159/000321390; PMid:21266792

13. Raju J, Patlolla MR, Swamy MV et al. 2004. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiology Biomarkers and Prevention 13(8):1392–1398. PMid:15298963

14. Durkar AM, Patil RR, Naik SR. 2014. Hypolipidemic and antioxidant activity of ethanolic extract of Symplocos racemosa Roxb. in hyperlipidemic rats: an evidence of participation of oxidative stress in hyperlipidemia. Indian J Exp Biol. 52(1):36–45. PMid:24617014

15. Jung M, Choi J, Chae S et al. 2014. Flavonoids from Symplocos racemosa. Molecules. 20(1):358–365. https://doi.org/10.3390/molecules20010358; PMid:25549060

16. Gallos ID, Ganesan R, Gupta JK. 2013. Prediction of regression and relapse of endometrial hyperplasia with conservative therapy. Obstet Gynecol. 121:1165–1171. https://doi.org/10.1097/AOG.0b013e31828cb563; PMid:23812448

17. Goyal S, Gupta N, Chatterjee S. 2016. Investigating Therapeutic Potential of Trigonella foenum-graecum L. as Our Defense Mechanism against Several Human Diseases. J Toxicol. 1:236–248.

18. Onlom C, Phrompittayarat W, Putalun W et al. 2017. Immunoaffinity knockout of saponin glycosides from Asparagus racemosus to assess anti-lipid peroxidation. Phytochem Anal. 15:267–268. https://doi.org/10.1002/pca.2678

19. Kaviarasan S, Naik GH, Gangabhagirathi R et al. 2007. In vitro studies on antiradical and antioxidant activity of (Trigonella foenum graecum) fenugreek seeds. Food Chemistry. 103:31–37. https://doi.org/10.1016/j.foodchem.2006.05.064

20. Scarselli G, Bargelli G, Taddei GL et al. 2011. Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyper plasia: a 15-year follow-up study. Fertil Steril. 95:420–422. https://doi.org/10.1016/j.fertnstert.2010.07.1044; PMid:20723889

21. Management of Endometrial Hyperplasia / Green-top Guideline RCOG BSOG Joint Guideline. 2016. Febr.:30.

22. Baker WD, Pierce SR, Mills AM et al. 2017. Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women. Gynecol Oncol. 18:82–85. https://doi.org/10.1016/j.ygyno.2017.04.006

23. Jernigan AM, Maurer KA, Cooper K et al. 2015. Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort study. Am J Obstet Gynecol. 213(350):1–10. https://doi.org/10.1016/j.ajog.2015.05.015

24. Gallos ID, Krishan P, Shehmar M et al. 2013. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Hum Reprod. 28:1231–1236. https://doi.org/10.1093/humrep/det320; https://doi.org/10.1093/humrep/det049; PMid:23466671

25. Singh R. 2016. Asparagus racemosus: a review on its phytochemical and therapeutic potential. Nat Prod Res. 30(17):1896–1908. https://doi.org/10.1080/14786419.2015.1092148; PMid:26463825